Generated August 15, 2026.
Figures quoted in this analysis are from its generation date and may lag the live snapshot table above, which always shows the latest data.
Overview
MSTR is MicroStrategy Incorporated, a software company that also maintains one of the largest corporate Bitcoin treasuries. MSTY is a YieldMax ETF that synthetically replicates MSTR's share price through a covered call options overlay, capping upside gains in exchange for weekly income distributions. The key distinction: MSTR is direct equity ownership with full upside exposure; MSTY is a derivative-based income strategy with capped appreciation and substantially higher current yield.
How they differ
MSTY's core mechanic is a covered call overlay on MSTR shares, which generates income by selling call options against the underlying position. This strategy caps your potential gains on MSTR stock movement in exchange for weekly distributions yielding 78.89% annualized, versus MSTR as a growth stock with no current payout. MSTY's beta of 2.5604 is notably lower than MSTR's 3.555, reflecting the downside protection and income ceiling built into the options structure. The ETF charges 0.99% annually and holds $753M in assets, while MSTR is a stock with no expense ratio and no fund wrapper. MSTY's one-week distribution frequency versus MSTR's growth-only posture represents a fundamental strategic divergence: trading price appreciation potential for predictable, frequent income.
Who each is best for
MSTR: Investors seeking maximum exposure to MicroStrategy's software business and Bitcoin treasury appreciation, with high risk tolerance and a multi-year time horizon. Fits those betting on Bitcoin's long-term trajectory and viewing MSTR's treasury strategy as a leveraged play on crypto upside.
MSTY: Investors drawn to MSTR's Bitcoin exposure but prioritizing current income over growth, willing to cap their upside in exchange for weekly distributions and moderately lower volatility. Suits those who want MSTR's direction without the full price swing and prefer regular cash flow.
Key risks to know
- NAV erosion at extreme yields: MSTY's 78.89% distribution rate is substantially higher than typical dividend-paying stocks and many covered call ETFs. Yields this elevated raise the likelihood that distributions include return of capital rather than pure earnings, which can erode share price over time.
- Capped upside from call overlay: By design, the covered calls on MSTR shares limit your gains if Bitcoin or MicroStrategy's software business outperforms. If MSTR rallies sharply, MSTY's price will lag—the income you collected may not offset forgone appreciation.
- Bitcoin volatility amplified: MSTR's 3.555 beta reflects extreme sensitivity to market moves; MSTY at 2.5604 is still highly volatile. Both securities are crypto-sensitive, and a significant Bitcoin drawdown could pressure both significantly, though MSTY's income cushion may help preserve some capital if shares decline.
- Single-stock concentration: Both securities track one company. Unlike a diversified portfolio, you're wholly exposed to MicroStrategy's execution risk, Board decisions on Bitcoin accumulation, and software competitive pressures.
- Options decay and call assignment risk: MSTY's strategy depends on continuous call writing. If MSTR is called away, the fund rolls to a new call strike; in a spike, assignment could force crystallization of gains at a cap. Additionally, as the fund rebalances options, transaction costs and timing slippage can erode returns.
Bottom line
If you want maximum Bitcoin and MicroStrategy upside with no income drag, MSTR offers direct ownership at volatility cost. If you value predictable weekly cash flow and can live with capped gains, MSTY's 78.89% yield and reduced beta appeal—though its extreme distribution rate warrants scrutiny for sustainability. Both carry significant concentration and crypto-related volatility; past performance doesn't predict future results.
AI-generated analysis for educational purposes only. Verify important details independently; past performance does not guarantee future results.